CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Lanzhou Foci Pharmaceutical Co Limited Company Snapshot
Lanzhou Foci Pharmaceutical Co Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lanzhou Foci Pharmaceutical Co Limited with three other companies in this sector in China: Beijing Beilu Pharmaceutical Company Limited (2017 sales of 522.54 million Chinese Renmimbi [US$75.17 million] of which 99% was Pharmaceutical Sales), Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (497.69 million Chinese Renmimbi [US$71.60 million] ), and Honz Pharmaceutical Co Ltd (480.81 million Chinese Renmimbi [US$69.17 million] of which 100% was Medical Industry).

Sales Analysis. During the year ended December of 2017, sales at Lanzhou Foci Pharmaceutical Co Limited were 501.14 million Chinese Renmimbi (US$72.09 million). This is an increase of 38.0% versus 2016, when the company's sales were 363.22 million Chinese Renmimbi. Sales of Pharmacies saw an increase of 38.5% in 2017, from 360.30 million Chinese Renmimbi to 498.88 million Chinese Renmimbi. Not all segments of Lanzhou Foci Pharmaceutical Co Limited experienced an increase in sales in 2017: sales of Food fell 23.7% to 2.26 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Lanzhou Foci Pharmaceutical Co Limited
  Stock Performance Chart for Lanzhou Foci Pharmaceutical Co Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): 8.98
(Figures in Chinese Renmimbi)
1 Week 3.8%   13 Weeks 7.0%  
4 Weeks 2.4%   52 Weeks -11.5%  
 
Lanzhou Foci Pharmaceutical Co Limited Key Data:
  Ticker: 002644 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 501,139,717
(Year Ending Jan 2018).
Employees: 1,475
  Currency: Chinese Renmimbi Market Cap: 4,585,699,860
  Fiscal Yr Ends: December Shares Outstanding: 510,657,000
  Share Type: A Gu Closely Held Shares: 328,592,234
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.